Investing.com - Financial Markets Worldwide
🤯 Have you seen our AI stock pickers’ 2024 results? 84.62%! Grab November’s list now.Pick Stocks with AI

AbbVie hikes 2024 earnings guidance as Q1 beat estimates, shares up

Published 26/04/2024, 09:46 pm
© Reuters
ABBV
-

AbbVie (NYSE:ABBV) shares rose 2.4% in premarket trading Friday after the company raised full-year guidance for adjusted earnings per share (EPS) as Q1 results beat expectations.

The pharmaceutical company reported earnings per share (EPS) of $2.31 for the fiscal Q1, exceeding the consensus estimate of $2.27. The company's revenue reached $12.31 billion, also above the projected $11.93 billion.

Looking ahead, AbbVie has updated its full-year earnings guidance, now anticipating adjusted EPS to be between $11.13 and $11.33. This revised forecast is an increase from the previously projected range of $10.97 to $11.17 and is slightly above the consensus estimate of $11.10.

The updated guidance includes an expected $0.08 per share negative impact due to expenses related to acquired IPR&D and milestones, company said.

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.